SI2112154T1 - Estri v poloĹľaju 20 kamptotecinov - Google Patents

Estri v poloĹľaju 20 kamptotecinov

Info

Publication number
SI2112154T1
SI2112154T1 SI200332302T SI200332302T SI2112154T1 SI 2112154 T1 SI2112154 T1 SI 2112154T1 SI 200332302 T SI200332302 T SI 200332302T SI 200332302 T SI200332302 T SI 200332302T SI 2112154 T1 SI2112154 T1 SI 2112154T1
Authority
SI
Slovenia
Prior art keywords
camptothecins
esters
Prior art date
Application number
SI200332302T
Other languages
English (en)
Inventor
Mauro Marzi
Domenico Alloatti
Claudio Pisano
Maria Ornella Tinti
Loredana Vesci
Franco Zunino
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Istituto Nazionale Per Lo Studio E La Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A., Istituto Nazionale Per Lo Studio E La Cura Dei Tumori filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of SI2112154T1 publication Critical patent/SI2112154T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
SI200332302T 2002-05-31 2003-05-28 Estri v poloĹľaju 20 kamptotecinov SI2112154T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000306A ITRM20020306A1 (it) 2002-05-31 2002-05-31 Esteri in posizione 20 di camptotecine.
EP09162737.2A EP2112154B1 (en) 2002-05-31 2003-05-28 Esters in position 20 of camptothecins

Publications (1)

Publication Number Publication Date
SI2112154T1 true SI2112154T1 (sl) 2013-12-31

Family

ID=11456339

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200332302T SI2112154T1 (sl) 2002-05-31 2003-05-28 Estri v poloĹľaju 20 kamptotecinov
SI200331685T SI1509529T1 (sl) 2002-05-31 2003-05-28 Estri na poziciji 20 kamptotecina

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200331685T SI1509529T1 (sl) 2002-05-31 2003-05-28 Estri na poziciji 20 kamptotecina

Country Status (22)

Country Link
US (2) US7452900B2 (sl)
EP (2) EP2112154B1 (sl)
JP (1) JP4593270B2 (sl)
KR (1) KR101000963B1 (sl)
CN (1) CN100376583C (sl)
AR (1) AR040140A1 (sl)
AT (1) ATE439362T1 (sl)
AU (1) AU2003241161C1 (sl)
CA (1) CA2487252C (sl)
CY (2) CY1109581T1 (sl)
DE (1) DE60328777D1 (sl)
DK (2) DK2112154T3 (sl)
ES (2) ES2432379T3 (sl)
HK (1) HK1079206A1 (sl)
IT (1) ITRM20020306A1 (sl)
MX (1) MXPA04011681A (sl)
PE (1) PE20040533A1 (sl)
PL (1) PL374009A1 (sl)
PT (2) PT2112154E (sl)
SI (2) SI2112154T1 (sl)
TW (1) TWI331151B (sl)
WO (1) WO2003101996A2 (sl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
NZ550430A (en) 2004-04-27 2009-06-26 Wellstat Biologics Corp Cancer treatment using viruses and camptothecins
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
WO2007011601A2 (en) 2005-07-14 2007-01-25 Wellstat Biologics Corporation Cancer treatment using viruses, fluoropyrimidines and camptothecins
CN103864811A (zh) * 2012-12-13 2014-06-18 天津科技大学 一种新颖的10-羟基喜树碱20位衍生物制备方法及其在抗肿瘤药物中的应用
WO2014121033A1 (en) * 2013-02-04 2014-08-07 Fl Therapeutics Llc Soluble complexes of drug analogs and albumin
US9937259B2 (en) 2014-06-27 2018-04-10 Zhuhai Beihai Biotech Co., Ltd. Abiraterone derivatives and non-covalent complexes with albumin
WO2016065139A1 (en) 2014-10-24 2016-04-28 Fl Therapeutics Llc 3-substituted piperidine-2, 6-diones and non-covalent complexes with albumin
US10517961B2 (en) 2015-09-25 2019-12-31 ZY Therapeutics, Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
CN106279286B (zh) * 2016-08-12 2018-11-30 华中科技大学 一种喜树碱膦酸酯类化合物、其制备方法及应用
CN110577551A (zh) * 2018-06-08 2019-12-17 遵义医学院 喜树碱-甘氨酸-5,6-二溴去甲斑蝥素结合物及其应用
US20220242874A1 (en) 2019-07-11 2022-08-04 Sun Pharma Advanced Research Company Limited Camptothecin derivatives
CN116514829A (zh) * 2020-08-21 2023-08-01 诺茗(北京)生物医药有限公司 一种水溶性抗肿瘤前药及其药物组合物和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP3186166B2 (ja) * 1992-02-10 2001-07-11 ロンザ リミテッド サリチロイル−カルニチンおよびその製造方法
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
JP3751025B2 (ja) 1995-12-15 2006-03-01 ザ デクスター コーポレイション 研摩性不織繊維ウェブ材料及びその製造方法
DE69923322T2 (de) 1998-07-30 2005-12-22 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Verwendung von propionyl-l-carnitin und acetyl-l-carnitin zur herstellung von arzneimittel mit antikrebs wirkung
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
PT1044977E (pt) 1999-03-09 2002-09-30 Sigma Tau Ind Farmaceuti Derivados de camptotecina com actividade antitumoral
DE19916945C1 (de) 1999-04-15 2000-10-05 Clariant Gmbh Aromatische Aldehydharze und ihre Verwendung als Emulsionsspalter
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
US6288072B1 (en) 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
US6629995B1 (en) 2000-03-31 2003-10-07 Super Gen, Inc. Camptothecin conjugates

Also Published As

Publication number Publication date
AR040140A1 (es) 2005-03-16
DE60328777D1 (en) 2009-09-24
PT2112154E (pt) 2013-10-02
EP1509529B1 (en) 2009-08-12
US20050256148A1 (en) 2005-11-17
DK2112154T3 (da) 2013-10-21
ITRM20020306A0 (it) 2002-05-31
PE20040533A1 (es) 2004-08-26
ITRM20020306A1 (it) 2003-12-01
CY1109581T1 (el) 2014-08-13
JP2005529935A (ja) 2005-10-06
CN100376583C (zh) 2008-03-26
WO2003101996A8 (en) 2004-04-29
ATE439362T1 (de) 2009-08-15
WO2003101996A3 (en) 2004-01-29
TW200403246A (en) 2004-03-01
KR101000963B1 (ko) 2010-12-13
EP2112154B1 (en) 2013-07-24
ES2432379T3 (es) 2013-12-03
WO2003101996A2 (en) 2003-12-11
CA2487252C (en) 2010-08-10
DK1509529T3 (da) 2009-12-14
MXPA04011681A (es) 2005-03-31
PL374009A1 (en) 2005-09-19
AU2003241161B2 (en) 2009-10-22
CA2487252A1 (en) 2003-12-11
EP1509529A2 (en) 2005-03-02
CN1656101A (zh) 2005-08-17
CY1114692T1 (el) 2016-10-05
SI1509529T1 (sl) 2009-12-31
KR20050036910A (ko) 2005-04-20
ES2331569T3 (es) 2010-01-08
JP4593270B2 (ja) 2010-12-08
AU2003241161A1 (en) 2003-12-19
US7452900B2 (en) 2008-11-18
US7498340B2 (en) 2009-03-03
EP2112154A1 (en) 2009-10-28
HK1079206A1 (en) 2006-03-31
PT1509529E (pt) 2009-11-13
AU2003241161C1 (en) 2010-03-04
US20070213353A1 (en) 2007-09-13
TWI331151B (en) 2010-10-01

Similar Documents

Publication Publication Date Title
HK1079206A1 (en) Esters in position 20 of camptothecins
EP1479666A4 (en) ESTER CONNECTION AND THEIR MEDICAL USE
GB0221697D0 (en) Novel compouds and their uses
HK1157760A1 (en) Benzimidazol-carbonyl-pyridinyl-amino-propionic acid ethyl ester hemihydrate and use thereof
EP1551384A4 (en) R-NSAID ESTERS AND ITS USE
AU2003252478A1 (en) Ccr4 antagonist and medicinal use thereof
EP1643972A4 (en) STABILIZED LIPOSOMAL TOPOTECAN COMPOSITION AND METHOD
EP1551398A4 (en) PYRAZOLOPYRIDINES AND METHODS OF MAKING AND USING THEM
GB0303609D0 (en) Novel therapeutic method and compositions
AU2003296369A8 (en) Imminoamines and preparation thereof
AU2003239868A8 (en) Sunscreen compositions and methods of use thereof
GB2411378B (en) Droplet-deposition related methods and appparatus
IL165112A0 (en) Variant integrinpolypeptides and thereof
EP1670755A4 (en) PYROVALERON ANALOGUE AND ITS THERAPEUTIC APPLICATIONS
EP1553945A4 (en) NITROXIDE RADIATION PROTECTION AND APPLICATION METHOD
GB0327050D0 (en) Therapeutic methods compositions and uses
PL370352A1 (en) 3-desoxy-vitamin d3 analog esters
WO2005042707A9 (en) Taspasel 1 and methods of use
GB0202187D0 (en) "Inhibitors"
GB0218261D0 (en) Improvements in pharmaceutically useful compounds
GB0303600D0 (en) Novel therapeutic method and compositions
AU2003220085A8 (en) Protein a compositions and methods of use
GB0205826D0 (en) Therapeutic compositions and methods
AU2003263224A8 (en) Polishing composition and methods
GB0209857D0 (en) Tee